Pharma reps need to bone up on scientific data and real-world evidence for oncology discussions: study

Oncologists would like a word with pharma companies. More than a word, actually – they’d like entire in-depth conversations with drug experts and more real-world data, please.

Nine out of 10 oncologists said talking to pharma companies about patients’ individual cases will influence future treatment decisions, versus just 43% who said product discussions would.